ReviewHeliyon2021
Fungi as veritable tool in current advances in nanobiotechnology.
Review in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Biocatalytic and biogenic pathways for sustainable nanoparticle synthesis: mechanisms, monitoring, and circular bioeconomy integration.Bioprocess and biosystems engineering · 2026Review
- Mycosynthesized Silver Nanoparticles (AgNPs) for the Control of Foodborne Pathogenic Bacteria:Microorganisms · 2026Article
- Gold Nanoparticles in Prostate Cancer: Advances in Targeted Therapy, Diagnostics, and Precision Nanomedicine.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Mycogenic Nanomaterials: What Fungal Nanoparticles Promise and What Still Holds Them Back.Journal of fungi (Basel, Switzerland) · 2026Review
- Medical importance and pharmacokinetics of gold nanoparticles in the human body.Molecular cancer · 2025Review
- Metal Nanoparticles: From Endophytic Fungi-Mediated Biosynthesis to Their Therapeutic Applications in Oncology.International journal of nanomedicine · 2025Review
- Nanotechnology for fungal pathogen control in crops: innovations, public health impacts, and disease prevention.Frontiers in fungal biology · 2025Review
- Unlocking the potential of titanium dioxide nanoparticles: an insight into green synthesis, optimizations, characterizations, and multifunctional applications.Microbial cell factories · 2024Review
- Valorization of plant by-products in the biosynthesis of silver nanoparticles with antimicrobial and catalytic properties.Environmental science and pollution research international · 2024Article
- Fungal-mediated synthesis of silver nanoparticles: a novel strategy for plant disease management.Frontiers in microbiology · 2024Article
- Exploring the antimicrobial, antioxidant, anticancer, biocompatibility, and larvicidal activities of selenium nanoparticles fabricated by endophytic fungal strain Penicillium verhagenii.Scientific reports · 2023Article
- Diversity of Mycogenic Oxide and Chalcogenide Nanoparticles: A Review.Biomimetics (Basel, Switzerland) · 2023Review
- Focus and Insights into the Synthetic Biology-Mediated Chassis of Economically Important Fungi for the Production of High-Value Metabolites.Microorganisms · 2023Review
- A review on synthesis and antibacterial potential of bio-selenium nanoparticles in the food industry.Frontiers in microbiology · 2023Review
- Diversity of Biogenic Nanoparticles Obtained by the Fungi-Mediated Synthesis: A Review.Biomimetics (Basel, Switzerland) · 2022Review
- Integracides: Tetracyclic Triterpenoids fromLife (Basel, Switzerland) · 2022Article
- The Biogenically Efficient Synthesis of Silver Nanoparticles Using the FungusJournal of fungi (Basel, Switzerland) · 2022Article
- Soil Fungi as Biomediator in Silver Nanoparticles Formation and Antimicrobial Efficacy.International journal of nanomedicine · 2022Article
- Fungal Mushrooms: A Natural Compound With Therapeutic Applications.Frontiers in pharmacology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungi have great prospects for synthesis, applications and developing new products in nanotechnology. In recent times, fungi use in nanotechnology is gaining more attention because of the ecological friendly state of their metabolite-mediated nanoparticles, their safety, amenability and applications in diverse fields. The diversity of the metabolites such as enzymes, polysaccharide, polypeptide, protein and other macro-molecules has made fungi a veritable tool for nanoparticles synthesis. Mechanism of fungal nano-biosynthesis from the molecular perspective has been extensively studied through various investigations on its green synthesized metal nanoparticles. Fungal nanobiotechnology has been applied in agricultural, medical and industrial sectors for goods and services improvement and delivery to mankind. Agriculturally, it has found applications in plant disease management and production of environmentally friendly, non-toxic insecticides, fungicides to enhance agricultural production in general. Medically, diagnosis and treatment of diseases, especially of microbial origin have been improved with fungal nanoparticles through more efficient drug delivery systems with great benefits to pharmaceutical industries. This review therefore explored fungal nanobiotechnology; mechanism of synthesis, characterization and potential applications in various fields of human endeavours for goods and services delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.